Carladenise Armbrister Edwards

CIK: 0001937412

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
May 18, 2026
Sale(S)
Direct
67.2K shares at avg. $3.42$230K
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jan 6, 2026
Award(A)
Direct
79.4K shares-
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Mar 7, 2025
Sale(S)
Direct
200K shares at avg. $3.61$722K
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Jan 6, 2025
Award(A)
Direct
61K shares-

		Type	Shares	Price		Ownership
May 18, 2026	CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE	Sale(S)	67,160	$3.42	$229,687	Direct
Jan 6, 2026	CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE	Award(A)	79,365	-	$0	Direct
Mar 7, 2025	CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE	Sale(S)	200,000	$3.61	$722,000	Direct
Jan 6, 2025	CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE	Award(A)	60,975	-	$0	Direct

1-4 of 4 transactions

About Edwards Carladenise Armbrister

Edwards Carladenise Armbrister (SEC CIK 0001937412) files insider reports with the SEC as Director of CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV).

Signal8 holds 4 ownership filings by Edwards Carladenise Armbrister, all Form 4s, filed between Jan 8, 2025 and May 19, 2026. Those filings report 4 transactions, from Jan 6, 2025 to May 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Edwards Carladenise Armbrister's filings is in WILMINGTON, DE.

Recent filings by Edwards Carladenise Armbrister

May 18, 2026: Open-market sale of CLOV shares (Form 4, code S).
Jan 6, 2026: Grant or award of CLOV shares (Form 4, code A).
Mar 7, 2025: Open-market sale of CLOV shares (Form 4, code S).
Jan 6, 2025: Grant or award of CLOV shares (Form 4, code A).

Other insiders filing for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Soares Karen, Chief Legal Officer
Reynoso Jamie L., CEO, Medicare Advantage
Toy Andrew, Chief Executive Officer
THORNTON JOSEPH CLAY, Interim CFO
Wai Conrad, CEO, Counterpart Health
Miller Brian James, Director

How to read Form 4 transaction codes